14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $110.93 Friday, 3rd May 2024 BPMC stock ended at $107.19. This is 0.178% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.50% from a day low at $106.15 to a day high of $110.93.
90 days $72.25 $110.93
52 weeks $43.89 $110.93

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Jan 22, 2021 $99.91 $101.93 $98.36 $101.36 344 204
Jan 21, 2021 $104.22 $105.74 $99.82 $99.86 385 467
Jan 20, 2021 $102.71 $104.43 $101.60 $104.22 286 623
Jan 19, 2021 $101.40 $102.79 $100.34 $102.35 340 213
Jan 15, 2021 $102.01 $103.00 $100.57 $100.99 293 698
Jan 14, 2021 $103.98 $106.38 $101.52 $102.51 440 849
Jan 13, 2021 $107.22 $108.44 $103.68 $103.97 358 644
Jan 12, 2021 $109.00 $111.03 $105.99 $107.22 411 735
Jan 11, 2021 $105.73 $108.75 $100.01 $107.00 446 119
Jan 08, 2021 $106.85 $108.70 $104.08 $108.28 588 048
Jan 07, 2021 $104.27 $107.26 $102.63 $106.84 539 937
Jan 06, 2021 $101.52 $104.92 $98.83 $104.78 557 972
Jan 05, 2021 $104.12 $107.92 $101.78 $102.23 597 435
Jan 04, 2021 $112.15 $113.47 $102.49 $104.57 909 199
Dec 31, 2020 $115.11 $115.47 $111.58 $112.15 377 043
Dec 30, 2020 $117.35 $119.94 $114.79 $115.00 281 275
Dec 29, 2020 $122.73 $123.07 $116.17 $116.67 346 904
Dec 28, 2020 $124.54 $124.54 $119.52 $122.45 429 751
Dec 24, 2020 $124.49 $125.61 $122.54 $123.00 83 913
Dec 23, 2020 $124.69 $124.71 $122.59 $124.48 225 009
Dec 22, 2020 $121.38 $124.39 $120.80 $123.72 387 667
Dec 21, 2020 $121.99 $123.63 $118.89 $121.68 606 810
Dec 18, 2020 $118.29 $123.97 $117.49 $123.64 2 796 995
Dec 17, 2020 $117.40 $118.31 $115.75 $118.17 483 017
Dec 16, 2020 $117.54 $119.50 $116.37 $117.39 446 081
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT